Impact of miRNA-192 for cisplatin resistance of non-small cell lung cancer A549/DDP cellsYANG Yucai, LIU Jing, WAN Li, LIU Fengzhen, WANG He, WANG Zhaoxia481-485
The regulatory mechanism of RhoA on VEGF expression in esophageal squamous cell carcinoma cell line Eca-109MA Ji, ZHAO Qingli, ZHONG Cuiping, LIU Wenchao, XUE Yan486-489
Expression of miR-122 in hepatocarcinoma cell strains and its relationship with PTENZHANG Ying, JIA Shaochang, XIANG Fang, LU Lei, WANG Xuan490-493
Enhanced activity of rituximab on Raji cells via 4-1BBL gene transfectionJIANG Wenguo, ZHANG Shuping, XU Yong, LUAN Haiyun494-497
The influence of autologous cytokine-induced killer cells therapy on immunity function of cancer patients in different stagesZHENG Zhendong, LIANG Xuefeng, QU Shuxian, HAN Tao, PIAO Ying, DING Zhenyu, YU Huiying, MA Dongchu, HAN Yaling, XIE Xiaodong498-502
Endoscopic management of upper gastrointestinal submucosal tumors:a retrospective review of 426 casesSHEN Shanshan, LING Tingsheng503-507
Expression of PFKFB3 in human primary hepatocellular carcinoma and its clinical significanceWU Erbin, LI Lihua, GUO Zijian508-511
Combination of fulvestrant and trastuzumab for the treatment of Luminal B (HER-2 positive) advanced breast cancers after prior aromatase inhibitorsWU Meihong, WANG Mei, WANG Wei, WANG Yajie512-515
Efficacy analysis of cetuximab plus chemotherapy for K-Ras wild-type colorectal cancer with metastasesQIN Rui, SHI Yan, CHEN Li, WU Zhiyong, HAN Yalin, DAI Guanghai516-523
Multivariate analysis of prognosis in patients with advanced gastric cancerZHANG Yaping, WEI Jia, YANG Yang, SHEN Jie, LIU Baorui524-529
